Nick Riehle
Chief Financial Officer
Cancer
Athenex
New Zealand
Biography
Nick is a veteran financial and business professional. Prior to joining Athenex, Nick served for 10 years as Vice President Administration and Chief Financial Officer at Chelsea Therapeutics, a NASDAQ-listed biopharmaceutical company which was acquired by H. Lundbeck A/S in 2014. Before Chelsea Therapeutics, Mr. Riehle served as Chief Financial Officer at HAHT Commerce, Inc., a software company, and prior to that served in various finance and marketing roles at Nortel Networks and IBM. Mr. Riehle has a Bachelor of Commerce from McGill University, an MBA from York University and earned a Certified Management Accountant (CMA) designation in Ontario, Canada.
Research Interest
Cancer
